Both the Food and Drug Administration green lighted a third dose of the COVID-19 vaccine for those with weakened immune systems on Thursday.
Now, booster shots are one step closer to being available in the community, as the Centers for Disease Control and Prevention recommended the dose for immunocompromised Americans.
The newly recommended booster shot by both Pfizer and Moderna allows for fully vaccinated people with compromised immune systems to receive an extra shot of protection.
That includes those with cancer, organ transplants, or other diagnosed health issues with less ability to fight off infections. Those conditions, meaning a third dose of the COVID-19 vaccine might be necessary to boost immunity.
The FDA says the vulnerable group capable of receiving the booster makes up for a small percent of the American population. Everyone else is encouraged to get vaccinated. Especially close contacts of anyone immunocompromised.
The FDA says the third dose should be administered at least 28 days after a second dose of the same vaccine; 18 years or older for Moderna, 12 years or older for Pfizer.
A booster shot hasn’t been approved or recommended for other fully vaccinated individuals just yet.